🚀 VC round data is live in beta, check it out!
Theraclion Overview
About Theraclion
Theraclion is a France-based company specializing in high-tech therapeutic ultrasound equipment. The product, Echopulse, helps in the treatment of breast fibroadenomas and benign thyroid nodules.
Founded
2004
HQ
Employees
29
Website
Sectors
Financials (FY)
EV
$36M
Theraclion Financials
Theraclion reported last fiscal year revenue of $977K and negative EBITDA of ($7M).
In the same fiscal year, Theraclion generated ($3M) in gross profit, ($7M) in EBITDA losses, and had net loss of ($7M).
Theraclion P&L
In the most recent fiscal year, Theraclion reported revenue of $977K and EBITDA of ($7M).
Theraclion expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $977K | XXX | XXX | XXX |
| Gross Profit | — | XXX | ($3M) | XXX | XXX | XXX |
| Gross Margin | — | XXX | (346%) | XXX | XXX | XXX |
| EBITDA | — | XXX | ($7M) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (710%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (820%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($7M) | XXX | XXX | XXX |
| Net Margin | — | XXX | (693%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Theraclion Stock Performance
Theraclion has current market cap of $35M, and enterprise value of $36M.
Market Cap Evolution
Theraclion's stock price is $0.59.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $36M | $35M | 5.8% | XXX | XXX | XXX | $-0.11 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialTheraclion Valuation Multiples
Theraclion trades at 37.0x EV/Revenue multiple, and (5.2x) EV/EBITDA.
Theraclion Financial Valuation Multiples
As of April 19, 2026, Theraclion has market cap of $35M and EV of $36M.
Equity research analysts estimate Theraclion's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Theraclion has a P/E ratio of (5.2x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $35M | XXX | $35M | XXX | XXX | XXX |
| EV (current) | $36M | XXX | $36M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 37.0x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (5.2x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (4.5x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | (10.7x) | XXX | XXX | XXX |
| P/E | — | XXX | (5.2x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (10.2x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Theraclion Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Theraclion Margins & Growth Rates
Theraclion's revenue in the last fiscal year declined by (54%).
Theraclion's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $0.2M for the same period.
Theraclion Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | (54%) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (710%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | 187% | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.0M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.2M | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 474% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Theraclion Public Comps
See public comps and valuation multiples for other Medical Devices comps.
Valuation data powered by FactSet, Inc.
Theraclion M&A Activity
Theraclion acquired XXX companies to date.
Last acquisition by Theraclion was on XXXXXXXX, XXXXX. Theraclion acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Theraclion
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialTheraclion Investment Activity
Theraclion invested in XXX companies to date.
Theraclion made its latest investment on XXXXXXXX, XXXXX. Theraclion invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Theraclion
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Theraclion
| When was Theraclion founded? | Theraclion was founded in 2004. |
| Where is Theraclion headquartered? | Theraclion is headquartered in France. |
| How many employees does Theraclion have? | As of today, Theraclion has over 29 employees. |
| Is Theraclion publicly listed? | Yes, Theraclion is a public company listed on Euronext Paris. |
| What is the stock symbol of Theraclion? | Theraclion trades under ALTHE ticker. |
| When did Theraclion go public? | Theraclion went public in 2014. |
| Who are competitors of Theraclion? | Theraclion main competitors are Implanet, Vivos, BrainCool, Myomo. |
| What is the current market cap of Theraclion? | Theraclion's current market cap is $35M. |
| What is the current revenue of Theraclion? | Theraclion's last fiscal year revenue is $977K. |
| What is the current EV/Revenue multiple of Theraclion? | Current revenue multiple of Theraclion is 37.0x. |
| Is Theraclion profitable? | No, Theraclion is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.